Marijuana legalization would open up new opportunities for Canopy Growth. Large multi-state operators, however, would also benefit from any reform in the U.S. Constellation Brands has been distancing itself from Canopy Growth, and that could have dire consequences for the cannabis producer.
President Biden has been reluctant to legalize marijuana, but he won't be president much longer. Vice President Harris has been more vocal in support of marijuana legalization, and now has a chance at the top job.
Canopy Growth Corporation (CGC) closed the most recent trading day at $7.13, moving -1.25% from the previous trading session.
In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $6.50, denoting a +0.31% change from the preceding trading day.
Canopy Growth parted ways with its CEO five years ago as it looked to improve its financial performance. The business has grown in five years, but it continues to struggle with profitability.
An election year means that talk of federal marijuana legalization is likely to ramp up in the months ahead. Multiple states, including Florida, could legalize recreational marijuana later this year.
Canopy Growth Corporation (CGC) reachead $6.67 at the closing of the latest trading day, reflecting a +0.6% change compared to its last close.
Canopy Growth has been slashing costs as it prepares to enter the U.S. pot market in the future. The stock often jumps in value anytime there are positive developments on the legalization front.
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Canopy Growth has pulled the trigger on its option to acquire Acreage Holdings. However, Canopy USA will ultimately be the acquirer, not Canopy Growth.
Canadian cannabis giant Canopy Growth Corporation (TSX:WEED, NYSE:CGC)'s recent strategy shift towards its US assets is a “critical” move, according to analysts at Jefferies. “Almost all of Canopy's value, in our view, is to come from its US assets,” the analysts wrote in a research note.
Canopy Growth isn't generating positive free cash flow, and never has. To keep its operations going, the company announced plans to sell about 32 million new shares of stock, and raise $250 million in cash.